Skip to main contentAI and Advanced
/
JLHL · NSEBSE SENSEX74,314.59-0.03%BSE |
NIFTY 5023,270.6+0.23%NSE |
NIFTY BANK56,055.75-0.42%NSE |
NIFTY IT29,155.6+0.23%NSE |
NIFTY AUTO27,159.15+0.99%NSE |
NIFTY FMCG45,572.7+0.03%NSE |
NIFTY PHARMA26,579.25+1.66%NSE |
NIFTY 50022,654.65+0.54%NSE |
JL
NSE · Equity shares · Healthcare Facilities2.95 · 1.07%
Jupiter Life Line Hospitals JLHL
NSE:INR 279.8
BSE:INR 276.85
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for JLHL
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 276.85
Day rangeINR 1,545.1 — INR 1,598
52-week rangeINR 235.6 — INR 1,618.15
Volume24,444
Market cap10,271.71
P/E43.3
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)1,499.79
Net Income (INR Cr)194.01
Rev Growth (5 Year %)25.27
P/E Ratio43.3
Book Value234.29
EPS30.15
Price/BV1.19Computed
Research path: Interpret Jupiter Life Line Hospitals's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
JLHLJupiter Life Line Hospitals1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 2,383.13 | 1,904.89 | 1,281.33 |
| Accumulated Depreciation Total | -394.37 | -310.44 | -286.03 |
| Other Liabilities Total | 16.46 | 5.01 | 3.09 |
| Long Term Debt | 500.9 | 321.75 | 0 |
| Common Stock Total | 65.57 | 65.57 | 65.57 |
| Other Current Assets Total | 1.12 | 0.91 | 0.02 |
| Prepaid Expenses | 10.57 | 9.73 | 5.76 |
| Total Assets | 2,383.13 | 1,904.89 | 1,281.33 |
| Current Portof LT Debt/Capital Leases | 17.81 | 9.06 | 0 |
| Additional Paid-In Capital | 664.33 | 664.33 | 664.33 |
| Cash | 58.17 | 131.64 | 23.01 |
| Total Equity | 1,544.08 | 1,356.24 | 1,169.04 |
| Long Term Investments | 0.1 | 1.42 | 21.83 |
| Retained Earnings(Accumulated Deficit) | 814.19 | 626.08 | 439.15 |
| Total Common Shares Outstanding | 6.56 | 6.56 | 6.56 |
| Property/Plant/Equipment Total-Gross | 1,899.5 | 1,468.4 | 1,075.54 |
| Tangible Book Valueper Share Common Eq | 234.29 | 206.16 | 177.97 |
| Total Liabilities | 839.05 | 548.65 | 112.3 |
| Total Debt | 584.24 | 393.15 | 0 |
| Short Term Investments | 485.7 | 471.29 | 295.11 |
| Cashand Short Term Investments | 543.87 | 602.93 | 318.12 |
| Total Receivables Net | 88.73 | 48.6 | 63.93 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 |
| Deferred Income Tax | 29.57 | 7.12 | 3.75 |
| Accounts Receivable-Trade Net | 75.54 | 41.89 | 57.21 |
| Property/Plant/Equipment Total-Net | 1,505.13 | 1,157.96 | 789.51 |
| Minority Interest | 0.01 | 0 | -0.3 |
| Total Current Liabilities | 226.58 | 152.43 | 105.75 |
| Total Inventory | 40.6 | 24.88 | 21.95 |
| Accounts Payable | 95.54 | 102.91 | 62.24 |
| Other Currentliabilities Total | 113.23 | 39.94 | 42.63 |
| Total Long Term Debt | 566.43 | 384.09 | 0 |
| Intangibles Net | 7.96 | 4.55 | 2.13 |
| Other Long Term Assets Total | 65.45 | 53.48 | 57.52 |
| Note Receivable-Long Term | 119.59 | 0.43 | 0.58 |
| Total Current Assets | 684.9 | 687.05 | 409.77 |
| Capital Lease Obligations | 65.53 | 62.34 | Not available |
| Accrued Expenses | Not available | 0.52 | 0.89 |
| Other Equity Total | Not available | 0.27 | Not available |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio1.37
Price to Sale Ratio6.85
Growth
Debt 5Yr CAGR %6.55
Margins
Operating Margin 12m16.76
Operating Margin 5y Avg17.69
Net Profit Margin 12m12.99
Net Profit Margin 5y12.61
Yield
Dividend Yield %0.06
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskModerate risk
Board Risk24.27
Analyst consensus
ConsensusStrong Buy
Consensus score1.40
Analyst opinions5
Strong Sell count0
Sell count0
Hold count0
Buy count2
Strong Buy count3
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Apollo Hospitals Enterprise | INR 8,898 | 1.28 L | 64.93 | — |
| Max Healthcare Institute | INR 1,088 | 1.06 L | 71.47 | — |
| Fortis Healthcare | INR 955 | 72,027.95 | 67.89 | — |
| Aster DM Healthcare | INR 799.05 | 41,159.91 | 102.55 | — |
| Narayana Hrudayalaya | INR 1,963 | 39,959.91 | 48.07 | — |
Shareholding
Ownership
- Promoter
- 40.91%
- FII
- 9.37%
- MF
- 10.89%
- Other
- 38.83%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Golden Cross Confirmed: Do Jupiter Life Line Hospitals Ltd's Other Technical Indicators Agree? - MarketsMojoMarket news · 21 Jul 2026, 1:32 am
Golden Cross Confirmed: Do Jupiter Life Line Hospitals Ltd's Other Technical Indicators Agree? MarketsMojo
Jupiter Life Line Hospitals Ltd Shows Mildly Bullish Momentum Amid Technical Shifts - MarketsMojoMarket news · 21 Jul 2026, 1:32 am
Jupiter Life Line Hospitals Ltd Shows Mildly Bullish Momentum Amid Technical Shifts MarketsMojo
Jupiter Hospital Opens Dombivli Unit As It Targets A 3,000-Bed Network - Business TodayMarket news · 20 Jul 2026, 3:28 pm
Jupiter Hospital Opens Dombivli Unit As It Targets A 3,000-Bed Network Business Today
Jupiter Life Line Hospitals Ltd: AGM Approves All Resolutions, Including Share Split - WhalesbookMarket news · 17 Jul 2026, 7:09 pm
Jupiter Life Line Hospitals Ltd: AGM Approves All Resolutions, Including Share Split Whalesbook
Jupiter Life Line Hospitals fixes July 24 record date for share split - scanx.tradeMarket news · 17 Jul 2026, 1:42 pm
Jupiter Life Line Hospitals fixes July 24 record date for share split scanx.trade
Jupiter Life Line Hospitals Approves Share Split, Appoints New Chairman at AGM - WhalesbookMarket news · 17 Jul 2026, 1:27 pm
Jupiter Life Line Hospitals Approves Share Split, Appoints New Chairman at AGM Whalesbook
Corporate actions
Events
- splitsStock split from Rs. 10/- to Rs. 2/-.
- annual General MeetingAGM
- dividendRs.1.0000 per share(10%)Interim Dividend
- board MeetingsQuarterly Results, Int. Dividend & Stock Split
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- dividendRs.1.0000 per share(10%)Final Dividend
Rusaka Markets Community
Discussion and sentiment for Jupiter Life Line Hospitals
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Jupiter Life Line Hospitals Limited is an India-based holding company. The Company is a multi-specialty tertiary and quaternary healthcare service provider in the Mumbai metropolitan area and western India. The Company has a total bed capacity of approximately 1,061 hospital beds across three hospitals. The Company operates three hospitals under the Jupiter brand in Thane, Pune, and Indore. It is equipped with over 30 specialty treatments, such as bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, endocrinology and diabetes, gastroenterology, infectious diseases, internal medicine, mental health, nephrology, neurology, neurosurgery, and nutrition and dietetics. The Company also owns Fortune Park Lake City Hotel in Thane for promoting medical tourism. The Company's subsidiaries include Jupiter Hospital Projects Private Limited and Medulla Healthcare Private Limited.
Company facts
- Industry
- Healthcare Facilities
- Sector
- Healthcare Facilities
- NSE Code
- JLHL
- BSE Code
- 543980
Questions
Stock FAQ
What is the symbol and ISIN of Jupiter Life Line Hospitals?
Jupiter Life Line Hospitals has the symbol JLHL and ISIN - INE682M01012.
What is the current price of Jupiter Life Line Hospitals?
Jupiter Life Line Hospitals is currently trading at INR 279.80.
What are the year high and year low of Jupiter Life Line Hospitals?
Jupiter Life Line Hospitals has a year high of INR 1,618.15 and a year low of INR 235.60.
What is the market capitalization of Jupiter Life Line Hospitals?
Jupiter Life Line Hospitals has a market capitalization of INR 10,271.71 crore.
What is the P/E ratio of Jupiter Life Line Hospitals?
Jupiter Life Line Hospitals has a P/E ratio of 43.30.
What is the dividend yield of Jupiter Life Line Hospitals?
Jupiter Life Line Hospitals has a dividend yield of 0.06%.
How is the financial performance of Jupiter Life Line Hospitals based on revenue, net income, and EPS?
Jupiter Life Line Hospitals has revenue of INR 1,499.79 crore, net income of INR 194.01 crore, and EPS of INR 30.15.
What is the book value of Jupiter Life Line Hospitals?
Jupiter Life Line Hospitals has a book value of INR 234.29.
What is the debt-to-equity ratio of Jupiter Life Line Hospitals?
Jupiter Life Line Hospitals has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Jupiter Life Line Hospitals?
Jupiter Life Line Hospitals has a price-to-book ratio of 1.19 and a price-to-sales ratio of 6.85.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.